The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Lumbar Spine Injury Clinical Trial

Official title:
The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine whether administration of a non-centrally acting muscle relaxants will improve the Overall Benefit of Analgesia Score (OBAS), and Richmond Agitation Sedation Scale (RASS) scores in patients undergoing lumbar fusion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03762109
Study type	Interventional
Source	Beth Israel Deaconess Medical Center
Contact	Richard J Pollard, MD
Phone	704-905-6637
Email	rpollard@bidmc.harvard.edu
Status	Recruiting
Phase	Phase 2
Start date	July 29, 2019
Completion date	December 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06156605` - Looking Beyond the Immediate Effects of Lumbar Spinal Manipulation Using Pain Pressure Threshold in Asymptomatic Individuals	N/A
Completed	`NCT03082248` - Second Opinion in Spinal Surgery Indications: Cost-Effectiveness Evaluation	N/A
Terminated	`NCT05034341` - Does Prehabilitation Improve Outcomes in Patients Undergoing Complex Spine Fusion Surgery?	N/A
Not yet recruiting	`NCT06100172` - Transcutaneous Auricular Neurostimulation After Lumbar Fusion Surgery	N/A
Recruiting	`NCT04937868` - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients